Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.

Between 1990 and 1999, 36 children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt), not associated with Down's syndrome, were diagnosed in Britain. A total of 31 children received intensive chemotherapy, six of whom proceeded to a bone marrow allograft in fi...

Full description

Bibliographic Details
Main Authors: Webb, D, Passmore, S, Hann, I, Harrison, G, Wheatley, K, Chessells, J
Format: Journal article
Language:English
Published: 2002
_version_ 1826279138960343040
author Webb, D
Passmore, S
Hann, I
Harrison, G
Wheatley, K
Chessells, J
author_facet Webb, D
Passmore, S
Hann, I
Harrison, G
Wheatley, K
Chessells, J
author_sort Webb, D
collection OXFORD
description Between 1990 and 1999, 36 children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt), not associated with Down's syndrome, were diagnosed in Britain. A total of 31 children received intensive chemotherapy, six of whom proceeded to a bone marrow allograft in first remission, whereas two received an autograft. Of the 23 given chemotherapy only, four died of toxicity, 10 relapsed and nine are alive in first remission. Out of the 10 who relapsed, four are alive and disease-free following an allograft. Out of the 6 children given an allograft in first remission, two died of disease and four are alive in first remission. Both children given an autograft died of disease. Two children received an allograft without prior chemotherapy but died of toxicity. Three children received supportive care only, and one child survived. The overall survival was 51% at 5 years, and was superior in children with RAEBt (63%) compared with RAEB (28%, P = 0.03). Cytogenetics were available in 35 cases. Monosomy 7 was the most common abnormality (33% of cases). Survival in children with monosomy 7 was 22% at 5 years compared with 66% for the other patients (P = 0.05). Allowing for cytogenetics, outcomes of therapy appear similar to those for de novo acute myeloid leukaemia (AML), and it is appropriate for children with RAEB/RAEBt to be registered in AML trials.
first_indexed 2024-03-06T23:54:19Z
format Journal article
id oxford-uuid:73ab79d7-6e69-4c7f-bafb-fedc1c8fc603
institution University of Oxford
language English
last_indexed 2024-03-06T23:54:19Z
publishDate 2002
record_format dspace
spelling oxford-uuid:73ab79d7-6e69-4c7f-bafb-fedc1c8fc6032022-03-26T19:57:59ZResults of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:73ab79d7-6e69-4c7f-bafb-fedc1c8fc603EnglishSymplectic Elements at Oxford2002Webb, DPassmore, SHann, IHarrison, GWheatley, KChessells, JBetween 1990 and 1999, 36 children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt), not associated with Down's syndrome, were diagnosed in Britain. A total of 31 children received intensive chemotherapy, six of whom proceeded to a bone marrow allograft in first remission, whereas two received an autograft. Of the 23 given chemotherapy only, four died of toxicity, 10 relapsed and nine are alive in first remission. Out of the 10 who relapsed, four are alive and disease-free following an allograft. Out of the 6 children given an allograft in first remission, two died of disease and four are alive in first remission. Both children given an autograft died of disease. Two children received an allograft without prior chemotherapy but died of toxicity. Three children received supportive care only, and one child survived. The overall survival was 51% at 5 years, and was superior in children with RAEBt (63%) compared with RAEB (28%, P = 0.03). Cytogenetics were available in 35 cases. Monosomy 7 was the most common abnormality (33% of cases). Survival in children with monosomy 7 was 22% at 5 years compared with 66% for the other patients (P = 0.05). Allowing for cytogenetics, outcomes of therapy appear similar to those for de novo acute myeloid leukaemia (AML), and it is appropriate for children with RAEB/RAEBt to be registered in AML trials.
spellingShingle Webb, D
Passmore, S
Hann, I
Harrison, G
Wheatley, K
Chessells, J
Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title_full Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title_fullStr Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title_full_unstemmed Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title_short Results of treatment of children with refractory anaemia with excess blasts (RAEB) and RAEB in transformation (RAEBt) in Great Britain 1990-99.
title_sort results of treatment of children with refractory anaemia with excess blasts raeb and raeb in transformation raebt in great britain 1990 99
work_keys_str_mv AT webbd resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099
AT passmores resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099
AT hanni resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099
AT harrisong resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099
AT wheatleyk resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099
AT chessellsj resultsoftreatmentofchildrenwithrefractoryanaemiawithexcessblastsraebandraebintransformationraebtingreatbritain199099